Company News »

Jeff Evanson Joins Navigant Life Sciences Practice as Managing Director

Business Wire
Share on StockTwits
Published on

Today, Navigant (NYSE:NCI) announced that Jeff Evanson has joined the Life Sciences practice as Managing Director. In his role, Evanson will assist Life Sciences clients’ growth plans through product and portfolio strategy, global launches and market development.

Evanson joins Navigant from Novartis (Alcon) where he was the Vice President and Global Commercial Head of the Pharmaceutical Franchise, a $4.2 billion division of Novartis (Alcon). During his four and a half year tenure there, he was responsible for aspects of strategy, portfolio, global brands, launches and campaigns initially for retina, then more broadly for all of the pharmaceutical products.

“Jeff is an innovative global business leader who brings a broad range of experience leading projects and building teams to identify growth opportunities in competitive environments and leveraging existing technology to expand into new therapeutic areas,” said Eduardo Schur, Managing Director and global leader of Navigant’s Life Sciences practice.

Prior to Novartis, Jeff spent 10 years at Medtronic in a variety of pre-commercialization and post-commercialization roles. He has extensive experience leading creating Opportunity Assessment through to Global Launch Plans and Life Cycle Management. These responsibilities allowed Jeff direct experience with global regulators and payers alike. Jeff also has experience in Pharmaceutical Sales and Sales Training.

“The pharmaceutical and medical technology industries are expanding at an incredible pace as innovation continues to fuel new growth. I am excited to join the team of experts within Navigant’s Life Sciences practice to strategize with our clients and help them achieve continued growth and developmental goals,” said Evanson.

Jeff received his MBA from the University of Minnesota and a BA in Chemistry from the University of St. Thomas in St. Paul Minnesota. He also has gained key insight and experience as a two-term Board Member of Gillette Children’s Hospital in St. Paul, Minnesota, from 2008 to 2014.

About Navigant

Navigant (NYSE:NCI) is a specialized, global professional services firm dedicated to assisting clients in creating and protecting value in the face of critical business risks and opportunities. Through senior level engagement with clients, Navigant professionals deliver expert and advisory work through implementation and business process management services. The firm combines deep technical expertise in Disputes and Investigations, Economics, Financial Advisory and Management Consulting, with business pragmatism to address clients’ needs in highly regulated industries, including Construction, Energy, Financial Services and Healthcare. More information about Navigant can be found at navigant.com.

Share on StockTwits